Ascendis Pharma A/S (ASND) income statement
ASNDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 7/30
$252.73−3.23 (-1.26%)
Close on Nov 20, 2026Market cap $15.66BP/E 20.8Yield –
Ascendis Pharma A/S financial ratios
See a number that looks wrong?